StonvexLoading…
StonvexStonvexStonvexCore line items from COLM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $779.01M | $3.40B | $2.33B | $1.38B |
Operating Income | $41.99M | $207.04M | $90.30M | $22.92M |
Net Income | $34.31M | $177.22M | $84.06M | $32.05M |
EPS (Diluted) | $0.65 | $3.24 | $1.53 | $0.58 |
Total Assets | $2.56B | $2.93B | $2.71B | $2.89B |
Total Liabilities | $981.62M | $1.22B | $1.06B | $1.24B |
Cash & Equivalents | $319.34M | $442.03M | $228.83M | $427.80M |
Free Cash Flow OCF − CapEx | $-89.99M | $216.74M | $-380.09M | $-92.92M |
Shares Outstanding | 51.14M | 53.49M | 55.11M | 55.40M |